Kevin Sayer

Kevin Sayer, CEO of Dexcom, shares his journey in medical devices and insights into continuous glucose monitors (CGMs). He highlights the profound impact of sleep and stress on glucose levels and how CGMs empower users to drive behavioral change. Sayer discusses exciting advancements, including the G6 model and partnerships aimed at improving accessibility. The conversation also delves into the complexities of diabetes management and the potential for CGMs to benefit not only diabetics but anyone looking to optimize health.

Kevin Sayer, the Chairman and CEO of Dexcom, transformed the company from $40 million to a $4 billion powerhouse in digital health. He reveals how real-time glucose monitoring has revolutionized diabetes care, empowering patients with crucial data. Kevin discusses the importance of trust in forging relationships with doctors and patients while navigating the transition from medical devices to consumer wellness. He also touches on future innovations in metabolic health and the impact of technology, including AI, on personalized health insights.

Bill Barker, a Motley Fool analyst, dives into Chewy's booming pet market and its reliance on auto-ship services, all while considering the challenges the company faces in sustaining growth. Kevin Sayer, CEO of Dexcom, discusses groundbreaking advancements in diabetes care tied to weight-loss drugs and the future of continuous glucose monitoring. The duo reflects on the changing landscape of pet care and the transformative impact of technology in managing health, making for a thought-provoking conversation on consumer trends and innovation.